Literature DB >> 23100412

Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats.

Viviana Trezza1, Ruth Damsteegt, Antonia Manduca, Stefania Petrosino, Linda W M Van Kerkhof, R Jeroen Pasterkamp, Yeping Zhou, Patrizia Campolongo, Vincenzo Cuomo, Vincenzo Di Marzo, Louk J M J Vanderschuren.   

Abstract

The brain endocannabinoid system plays a crucial role in emotional processes. We have previously identified an important role for endocannabinoids in social play behavior, a highly rewarding form of social interaction in adolescent rats. Here, we tested the hypothesis that endocannabinoid modulation of social play behavior occurs in brain regions implicated in emotion and motivation. Social play increased levels of the endocannabinoid anandamide in the amygdala and nucleus accumbens (NAc), but not in prefrontal cortex or hippocampus of 4- to 5-week-old male Wistar rats. Furthermore, social play increased phosphorylation of CB1 cannabinoid receptors in the amygdala. Systemic administration of the anandamide hydrolysis inhibitor URB597 increased social play behavior, and augmented the associated elevation in anandamide levels in the amygdala, but not the NAc. Infusion of URB597 into the basolateral amygdala (BLA) increased social play behavior, and blockade of BLA CB1 cannabinoid receptors with the antagonist/inverse agonist SR141716A prevented the play-enhancing effects of systemic administration of URB597. Infusion of URB597 into the NAc also increased social play, but blockade of NAc CB1 cannabinoid receptors did not antagonize the play-enhancing effects of systemic URB597 treatment. Last, SR141716A did not affect social play after infusion into the core and shell subregions of the NAc, while it reduced social play when infused into the BLA. These data show that increased anandamide signaling in the amygdala and NAc augments social play, and identify the BLA as a prominent site of action for endocannabinoids to modulate the rewarding properties of social interactions in adolescent rats.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23100412      PMCID: PMC3496852          DOI: 10.1523/JNEUROSCI.0114-12.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  74 in total

Review 1.  Putting a spin on the dorsal-ventral divide of the striatum.

Authors:  Pieter Voorn; Louk J M J Vanderschuren; Henk J Groenewegen; Trevor W Robbins; Cyriel M A Pennartz
Journal:  Trends Neurosci       Date:  2004-08       Impact factor: 13.837

2.  MICAL-1 is a negative regulator of MST-NDR kinase signaling and apoptosis.

Authors:  Yeping Zhou; Youri Adolfs; W W M Pim Pijnappel; Stephen J Fuller; Roel C Van der Schors; Ka Wan Li; Peter H Sugden; August B Smit; Alexander Hergovich; R Jeroen Pasterkamp
Journal:  Mol Cell Biol       Date:  2011-07-05       Impact factor: 4.272

3.  Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function.

Authors:  Daniela Cota; Michel-Alexander Steiner; Giovanni Marsicano; Cristina Cervino; James P Herman; Yvonne Grübler; Johanna Stalla; Renato Pasquali; Beat Lutz; Günter K Stalla; Uberto Pagotto
Journal:  Endocrinology       Date:  2006-12-28       Impact factor: 4.736

4.  Variation in the human cannabinoid receptor CNR1 gene modulates gaze duration for happy faces.

Authors:  Bhismadev Chakrabarti; Simon Baron-Cohen
Journal:  Mol Autism       Date:  2011-06-29       Impact factor: 7.509

Review 5.  Role of endogenous cannabinoids in synaptic signaling.

Authors:  Tamas F Freund; Istvan Katona; Daniele Piomelli
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

Review 6.  An introduction to the endocannabinoid system: from the early to the latest concepts.

Authors:  Luciano De Petrocellis; Vincenzo Di Marzo
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2009-02       Impact factor: 4.690

7.  Conditioned place preference induced by social play behavior: parametrics, extinction, reinstatement and disruption by methylphenidate.

Authors:  Viviana Trezza; Ruth Damsteegt; Louk J M J Vanderschuren
Journal:  Eur Neuropsychopharmacol       Date:  2009-05-08       Impact factor: 4.600

8.  Methylphenidate disrupts social play behavior in adolescent rats.

Authors:  Louk J M J Vanderschuren; Viviana Trezza; Sanne Griffioen-Roose; Olga J G Schiepers; Natascha Van Leeuwen; Taco J De Vries; Anton N M Schoffelmeer
Journal:  Neuropsychopharmacology       Date:  2008-02-27       Impact factor: 7.853

9.  Effects of endocannabinoid system modulation on cognitive and emotional behavior.

Authors:  Claudio Zanettini; Leigh V Panlilio; Mano Alicki; Steven R Goldberg; József Haller; Sevil Yasar
Journal:  Front Behav Neurosci       Date:  2011-09-13       Impact factor: 3.558

Review 10.  Endocannabinoid system and synaptic plasticity: implications for emotional responses.

Authors:  María-Paz Viveros; Eva-María Marco; Ricardo Llorente; Meritxell López-Gallardo
Journal:  Neural Plast       Date:  2007       Impact factor: 3.599

View more
  71 in total

1.  Cannabinoid CB1 receptor inhibition blunts adolescent-typical increased binge alcohol and sucrose consumption in male C57BL/6J mice.

Authors:  Abigail E Agoglia; Sarah E Holstein; Vallari R Eastman; Clyde W Hodge
Journal:  Pharmacol Biochem Behav       Date:  2016-01-19       Impact factor: 3.533

2.  An endocannabinoid-regulated basolateral amygdala-nucleus accumbens circuit modulates sociability.

Authors:  Oakleigh M Folkes; Rita Báldi; Veronika Kondev; David J Marcus; Nolan D Hartley; Brandon D Turner; Jade K Ayers; Jordan J Baechle; Maya P Misra; Megan Altemus; Carrie A Grueter; Brad A Grueter; Sachin Patel
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

3.  Methylphenidate and atomoxetine inhibit social play behavior through prefrontal and subcortical limbic mechanisms in rats.

Authors:  E J Marijke Achterberg; Linda W M van Kerkhof; Ruth Damsteegt; Viviana Trezza; Louk J M J Vanderschuren
Journal:  J Neurosci       Date:  2015-01-07       Impact factor: 6.167

Review 4.  On the interaction between drugs of abuse and adolescent social behavior.

Authors:  Viviana Trezza; Petra J J Baarendse; Louk J M J Vanderschuren
Journal:  Psychopharmacology (Berl)       Date:  2014-02-20       Impact factor: 4.530

5.  Dissociating the role of endocannabinoids in the pleasurable and motivational properties of social play behaviour in rats.

Authors:  E J Marijke Achterberg; Maaike M H van Swieten; Nina V Driel; Viviana Trezza; Louk J M J Vanderschuren
Journal:  Pharmacol Res       Date:  2016-05-03       Impact factor: 7.658

6.  Effects of cocaine combined with a social cue on conditioned place preference and nucleus accumbens monoamines after isolation rearing in rats.

Authors:  Susan K Grotewold; Vanessa L Wall; Dayton J Goodell; Cassandra Hayter; Sondra T Bland
Journal:  Psychopharmacology (Berl)       Date:  2014-02-20       Impact factor: 4.530

7.  Activation of basolateral amygdala in juvenile C57BL/6J mice during social approach behavior.

Authors:  Sarah L Ferri; Arati S Kreibich; Matthew Torre; Cara T Piccoli; Holly Dow; Ashley A Pallathra; Hongzhe Li; Warren B Bilker; Ruben C Gur; Ted Abel; Edward S Brodkin
Journal:  Neuroscience       Date:  2016-08-09       Impact factor: 3.590

8.  Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling.

Authors:  V M Doenni; J M Gray; C M Song; S Patel; M N Hill; Q J Pittman
Journal:  Brain Behav Immun       Date:  2016-07-21       Impact factor: 7.217

Review 9.  Reward Processing and Risk for Depression Across Development.

Authors:  Katherine R Luking; David Pagliaccio; Joan L Luby; Deanna M Barch
Journal:  Trends Cogn Sci       Date:  2016-04-27       Impact factor: 20.229

10.  Cellular activation in limbic brain systems during social play behaviour in rats.

Authors:  Linda W M van Kerkhof; Viviana Trezza; Tessa Mulder; Ping Gao; Pieter Voorn; Louk J M J Vanderschuren
Journal:  Brain Struct Funct       Date:  2013-05-14       Impact factor: 3.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.